Brendon Neuen

0 Followers

Dr Brendon Neuen is an academic nephrology registrar and NHMRC Postgraduate Scholar at The George Institute for Global Health. His research focuses on the cardiovascular and kidney protective effects of new glucose-lowering agents in people with diabetic kidney disease, having trained on the CANVAS Program and CREDENCE trial. He is also involved in several analyses of large-scale observational studies using routinely collected data, both in Australia and the United Kingdom.

clinical trials meta-analysis kidney disease diabetes sglt2

Aktivität
Info

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes

Vor 3 Jahren • 511 Aufrufe

Dr Brendon Neuen is an academic nephrology registrar and NHMRC Postgraduate Scholar at The George Institute for Global Health. His research focuses on the cardiovascular and kidney protective effects of new glucose-lowering agents in people with diabetic kidney disease, having trained on the CANVAS Program and CREDENCE trial. He is also involved in several analyses of large-scale observational studies using routinely collected data, both in Australia and the United Kingdom.

clinical trials meta-analysis kidney disease diabetes sglt2

Brendon Neuen

Präsentationen

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes